1. Clinical presentation assessment
A detailed history includes prior HPV infection and a history of anal intercourse. Comprehensive examination assesses tumor location, size, and its relationship to the anal sphincter complex.
2. Digital anorectal examination
Palpation of the anal canal and rectum to detect masses is a simple and effective initial screening approach.
3. Anoscopy
A lighted scope is inserted into the anal canal to visualize the mucosa, and targeted biopsy can be obtained from suspicious areas.
4. Imaging examinations
Ultrasound, MRI, CT, and PET-CT can delineate tumor location and size and contribute to staging assessment.
5. Pathological biopsy
Histopathology of sampled tissue is the primary basis for confirming malignancy and establishing the diagnosis.
6. Endoanal ultrasound
High-frequency ultrasound provides precise assessment of depth of invasion and sphincter involvement.
7. Tumor marker testing
HPV testing and related biomarkers can support diagnosis and may be used to monitor treatment response.
8. Staging investigations
Assessment of whether the cancer has spread helps define disease extent and informs treatment planning.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that anal cancer has a complex diagnostic pathway, and early symptoms are nonspecific and often misattributed to hemorrhoids, leading to late detection in many patients. Vigilance for bleeding and pain is crucial. High-risk individuals should undergo regular screening and seek timely medical evaluation for definitive diagnosis. Early standardized treatment can improve outcomes, and MDT-based collaboration can enhance diagnostic and therapeutic effectiveness.
1. Clinical presentation assessment
A detailed history includes prior HPV infection and a history of anal intercourse. Comprehensive examination assesses tumor location, size, and its relationship to the anal sphincter complex.
2. Digital anorectal examination
Palpation of the anal canal and rectum to detect masses is a simple and effective initial screening approach.
3. Anoscopy
A lighted scope is inserted into the anal canal to visualize the mucosa, and targeted biopsy can be obtained from suspicious areas.
4. Imaging examinations
Ultrasound, MRI, CT, and PET-CT can delineate tumor location and size and contribute to staging assessment.
5. Pathological biopsy
Histopathology of sampled tissue is the primary basis for confirming malignancy and establishing the diagnosis.
6. Endoanal ultrasound
High-frequency ultrasound provides precise assessment of depth of invasion and sphincter involvement.
7. Tumor marker testing
HPV testing and related biomarkers can support diagnosis and may be used to monitor treatment response.
8. Staging investigations
Assessment of whether the cancer has spread helps define disease extent and informs treatment planning.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that anal cancer has a complex diagnostic pathway, and early symptoms are nonspecific and often misattributed to hemorrhoids, leading to late detection in many patients. Vigilance for bleeding and pain is crucial. High-risk individuals should undergo regular screening and seek timely medical evaluation for definitive diagnosis. Early standardized treatment can improve outcomes, and MDT-based collaboration can enhance diagnostic and therapeutic effectiveness.